S&P 500   2,747.59 (+3.32%)
DOW   23,382.92 (+3.22%)
QQQ   200.73 (+2.20%)
AAPL   265.58 (+2.37%)
FB   173.70 (+2.88%)
MSFT   165.24 (+1.07%)
GOOGL   1,210.57 (+2.37%)
AMZN   2,037.44 (+1.28%)
CGC   14.88 (+2.62%)
NVDA   266.45 (+2.86%)
BABA   195.57 (-1.23%)
MU   48.53 (+4.28%)
TSLA   546.34 (+0.16%)
T   29.76 (-1.06%)
ACB   0.86 (+7.51%)
F   5.02 (+6.36%)
NFLX   369.91 (-0.87%)
BAC   23.38 (+5.60%)
DIS   100.46 (-0.77%)
PRI   97.49 (+10.71%)
S&P 500   2,747.59 (+3.32%)
DOW   23,382.92 (+3.22%)
QQQ   200.73 (+2.20%)
AAPL   265.58 (+2.37%)
FB   173.70 (+2.88%)
MSFT   165.24 (+1.07%)
GOOGL   1,210.57 (+2.37%)
AMZN   2,037.44 (+1.28%)
CGC   14.88 (+2.62%)
NVDA   266.45 (+2.86%)
BABA   195.57 (-1.23%)
MU   48.53 (+4.28%)
TSLA   546.34 (+0.16%)
T   29.76 (-1.06%)
ACB   0.86 (+7.51%)
F   5.02 (+6.36%)
NFLX   369.91 (-0.87%)
BAC   23.38 (+5.60%)
DIS   100.46 (-0.77%)
PRI   97.49 (+10.71%)
S&P 500   2,747.59 (+3.32%)
DOW   23,382.92 (+3.22%)
QQQ   200.73 (+2.20%)
AAPL   265.58 (+2.37%)
FB   173.70 (+2.88%)
MSFT   165.24 (+1.07%)
GOOGL   1,210.57 (+2.37%)
AMZN   2,037.44 (+1.28%)
CGC   14.88 (+2.62%)
NVDA   266.45 (+2.86%)
BABA   195.57 (-1.23%)
MU   48.53 (+4.28%)
TSLA   546.34 (+0.16%)
T   29.76 (-1.06%)
ACB   0.86 (+7.51%)
F   5.02 (+6.36%)
NFLX   369.91 (-0.87%)
BAC   23.38 (+5.60%)
DIS   100.46 (-0.77%)
PRI   97.49 (+10.71%)
S&P 500   2,747.59 (+3.32%)
DOW   23,382.92 (+3.22%)
QQQ   200.73 (+2.20%)
AAPL   265.58 (+2.37%)
FB   173.70 (+2.88%)
MSFT   165.24 (+1.07%)
GOOGL   1,210.57 (+2.37%)
AMZN   2,037.44 (+1.28%)
CGC   14.88 (+2.62%)
NVDA   266.45 (+2.86%)
BABA   195.57 (-1.23%)
MU   48.53 (+4.28%)
TSLA   546.34 (+0.16%)
T   29.76 (-1.06%)
ACB   0.86 (+7.51%)
F   5.02 (+6.36%)
NFLX   369.91 (-0.87%)
BAC   23.38 (+5.60%)
DIS   100.46 (-0.77%)
PRI   97.49 (+10.71%)
Log in

CVE:BCTBriacell Therapeutics Stock Price, Forecast & News

C$9.30
0.00 (0.00 %)
(As of 04/8/2020 03:38 PM ET)
Add
Compare
Today's Range
C$9.30
Now: C$9.30
C$9.30
50-Day Range
C$8.55
MA: C$17.03
C$25.00
52-Week Range
C$8.55
Now: C$9.30
C$33.00
Volume100 shs
Average Volume964 shs
Market CapitalizationC$6.71 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
BriaCell Therapeutics Corp., an immuno-oncology focused biotechnology company, develops personalized treatments for cancer. Its lead product candidate is Bria-IMT, a clinical trial in combination with pembrolizumab (KEYTRUDA; manufactured by Merck & Co., Inc.) for use in patients with breast cancer. The company is also developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer patients; and BriaDX, its companion diagnostic test. Its preclinical small molecule program consists of protein kinase C delta inhibitors for cancer and fibrotic diseases. BriaCell Therapeutics Corp. has a clinical trial collaboration and supply agreement with Incyte Corporation for developing Bria-IMT with compounds for treating breast cancer. The company is headquartered in West Vancouver, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.54 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-604-9211810

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Cash FlowC$0.12 per share
Book ValueC($1.49) per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$6.71 million
Next Earnings Date6/25/2020 (Estimated)
OptionableNot Optionable

Receive BCT News and Ratings via Email

Sign-up to receive the latest news and ratings for BCT and its competitors with MarketBeat's FREE daily newsletter.


Briacell Therapeutics (CVE:BCT) Frequently Asked Questions

How has Briacell Therapeutics' stock been impacted by COVID-19 (Coronavirus)?

Briacell Therapeutics' stock was trading at C$17.80 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, BCT stock has decreased by 47.8% and is now trading at C$9.30. View which stocks have been mosted impacted by Coronavirus.

When is Briacell Therapeutics' next earnings date?

Briacell Therapeutics is scheduled to release its next quarterly earnings announcement on Thursday, June 25th 2020. View our earnings forecast for Briacell Therapeutics.

Has Briacell Therapeutics been receiving favorable news coverage?

News coverage about BCT stock has been trending very negative on Wednesday, InfoTrie Sentiment reports. The research firm rates the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Briacell Therapeutics earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news aboutBriacell Therapeutics.

Who are some of Briacell Therapeutics' key competitors?

What other stocks do shareholders of Briacell Therapeutics own?

Who are Briacell Therapeutics' key executives?

Briacell Therapeutics' management team includes the following people:
  • Dr. William V. Williams M.D., CEO, Pres & Director
  • Dr. Charles Louis Wiseman M.D., FACP, Founder & Director
  • Mr. Gadi Levin B.Com., C.A., M.B.A., CPA, MBA, CFO & Corp. Sec. (Age 46)
  • Ms. Farrah Dean, Mang. of Corp. Devel.

What is Briacell Therapeutics' stock symbol?

Briacell Therapeutics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "BCT."

How do I buy shares of Briacell Therapeutics?

Shares of BCT and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Briacell Therapeutics' stock price today?

One share of BCT stock can currently be purchased for approximately C$9.30.

How big of a company is Briacell Therapeutics?

Briacell Therapeutics has a market capitalization of C$6.71 million.  View additional information about Briacell Therapeutics.

What is Briacell Therapeutics' official website?

The official website for Briacell Therapeutics is http://www.briacell.com/.

How can I contact Briacell Therapeutics?

Briacell Therapeutics' mailing address is Bellevue Centre, 235 15th St 3rd Floor, WEST VANCOUVER, BC V7T 2X1, Canada. The company can be reached via phone at +1-604-9211810.

This page was last updated on 4/8/2020 by MarketBeat.com Staff

Featured Article: Earnings Reports

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel